Pfizer COVID-19 Shot Recipients Show Higher Death Risk Than Moderna Counterpart
A major new peer-reviewed study from Florida has found a significant difference in mortality outcomes between two major COVID-19 shots. The post Pfizer COVID-19 Shot Recipients Show Higher Death Risk Than Moderna Counterpart appeared first on The Gateway Pundit.
A peer-reviewed study of nearly two million Florida adults found that those who received the Pfizer-BioNTech COVID-19 vaccine had a higher risk of death from any cause over 12 months compared to recipients of the Moderna vaccine. The disparity was most severe among individuals aged 60 and older, with significant increases in cardiovascular fatalities and COVID-19-related deaths for Pfizer recipients. Epidemiologist Nicholas Hulscher suggested these findings warrant urgent regulatory scrutiny and transparent public disclosure, advocating for the mRNA injections to be pulled from the market.
- A Florida study found Pfizer-BioNTech vaccine recipients had a 40% higher risk of death from any cause over 12 months compared to Moderna recipients.
- The disparity was most severe in patients 60 and older, with increased cardiovascular and COVID-19-related fatalities.
- An epidemiologist calculated potential excess deaths ranging from over 331,500 to 522,000 nationwide based on the study’s findings.
- The study’s findings are presented as demanding urgent regulatory scrutiny, transparent public disclosure, and informed consent regarding differences between vaccine products.
Write a comment